Kumar CC. Genetic Abnormalities and challenges in the treatment of Acute myeloid leukemia. Genes Cancer. 2011;2(2):95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):577.

Article  Google Scholar 

Padda J, Khalid K, Kakani V, et al. Metabolic Acidosis Leuk Cureus. 2021;13(9):e17732.

Google Scholar 

Dong Y, Shi O, Zeng Q, et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020;9(1):1–11.

Article  Google Scholar 

Schneider P, Castro PG, Pinhanços SM, et al. Decitabine mildly attenuates MLL-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer. EJHaem. 2020;1(2):527–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rogstad DK, Herring JL, Theruvathu JA, et al. Chemical decomposition of 5-aza-2’-deoxycytidine (decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry. Chem Res Toxicol. 2009;22(6):1194–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panchal K, Katke S, Dash SK, et al. An expanding horizon of complex injectable products: development and regulatory considerations. Drug Deliv Transl Res. 2023;13:433–72.

Article  PubMed  Google Scholar 

Chaurasiya A, Patra P, Thathireddy P. PLGA-Based Micro- and Nano-particles From Lab to Marke. In: Arvind NKM, editor. Micro- and Nanotechnologies-Based Product Development. CRC; 2021. p. 326.

Google Scholar 

Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377.

Article  CAS  PubMed  Google Scholar 

Padín-González E, Lancaster P, Bottini M, et al. Understanding the role and impact of Poly (Ethylene Glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines. Front Bioeng Biotechnol. 2022;10:882363.

Article  PubMed  PubMed Central  Google Scholar 

Essa D, Kondiah PPD, Choonara YE. The design of poly(lactide-co-glycolide) nanocarriers for medical applications. Front Bioeng Biotechnol. 2020;8:503602.

Article  Google Scholar 

Waghule T, Dabholkar N, Gorantla S, et al. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): a risk based industrial approach. Biomed Pharmacother. 2021;141:111940.

Article  CAS  PubMed  Google Scholar 

Srinivas NSK, Verma R, Kulyadi GP. A quality by design approach on polymeric nanocarrier delivery of gefitinib formulation in vitro and in vivo characterization. Int J Nanomed. 2017;12:15.

Article  CAS  Google Scholar 

Park SJ, Choo GH, Hwang SJ. Quality by design: screening of critical variables and formulation optimization of Eudragit nanoparticles containing dutasteride. Arch Pharm Res. 2013;36:593–601.

Article  CAS  PubMed  Google Scholar 

Mishra SM, Rohera BD. An integrated quality by design (QbD) approach for design development and optimization of orally disintegrating tablet formulation of carbamazepine. Pharm Dev Technol. 2017;22:889–903.

Article  CAS  PubMed  Google Scholar 

Jena GK, Patra CN, Panigrahi KC, et al. QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity. Drug Deliv Transl Res. 2022;12(6):1521–39.

Article  CAS  PubMed  Google Scholar 

Chen C, Yang W, Wang DT et al. A modified spontaneous emulsification solvent diffusion method for the preparation of curcumin-loaded PLGA nanoparticles with enhanced in vitro anti-tumor activity. Front Mater Sci 2014; 8:332–42.

Article  Google Scholar 

Kaur A, Bhoop BS, Chhibber S, et al. Supramolecular nano-engineered lipidic carriers based on diflunisal-phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int J Pharm. 2017;533(1):206–24.

Article  CAS  PubMed  Google Scholar 

Panchal K, Reddy A, Chaurasiya A. Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product. Drug Deliv Transl Res. 2024.

Nugraheni Raditya W, Setyawan D, Yusuf H. Physical characteristics of liposomal formulation dispersed in HPMC Matrix and Freeze-dried using maltodextrin and Mannitol as Lyoprotectant. Pharm Sci. 2017;23:285–92.

Article  Google Scholar 

De Jonge N, Ross FM. Electron microscopy of specimens in liquid. Nat Nanotechnol 2011;6:695–704.

Article  PubMed  Google Scholar 

Alimunnisa A, Rao L. RP-HPLC Method Development and Validation for simultaneous determination of decitabine and cedazuridine in pure and Tablet Dosage Form. Curr Trends Biotechnol Pharm. 2022;16(2):31–9.

CAS  Google Scholar 

Purushothaman M, Viswanath V, Narashimha Rao B. Preparation and evaluation of decitabine liposomes. IAJPS. 2015;2(9):1264–73.

CAS  Google Scholar 

Shukla R, Gupta J, Shukla P. Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis. RSC Adv. 2015;5:69047–56.

Article  CAS  Google Scholar 

Brus J, Czernek J, Kobera L, et al. Predicting the Crystal structure of decitabine by powder NMR crystallography: influence of Long-Range Molecular Packing Symmetry on NMR parameters. Cryst Growth Des. 2016;16(12):7102–11.

Article  CAS  Google Scholar 

Chaurasiya A, Gorajiya A, Jayabalan N. In: Saurabh, Srivastava, editors. Stability Testing Parameters of Nano scaled Product Development in: Neelesh Kumar Mehra. Multifunctional Nanocarriers. Elsevier; 2022. pp. 475–500.

Google Scholar 

Roosendaal J, Wang K, Rosing H. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β-decitabine in human plasma, whole blood and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1109:132–41.

Article  CAS  PubMed  Google Scholar 

Liu G, McEnnis K. Glass Transition Temperature of PLGA Particles and the influence on drug delivery applications. Polym (Basel). 2022;14(5):993.

Article  CAS  Google Scholar